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Policy Options:
The New Zealand health system, already struggling to 
meet demand for joint replacement surgeries, will be 
placed under greater pressure by rising rates of OA. 
1. Deliver the #1 most-recommended 
treatment (exercise therapy) nationwide
Research Findings:
2: Develop a national Model of Care (MoC) for the management of osteoarthritis
Delivering all core recommended interventions would result 
in significant health gains (> 10000 QALYs per year) and 
would be highly cost-effective.
Delivering the #1 most-recommended treatment (exercise 
therapy) would result in large health gains at relatively low cost 
to the health system ($25m per year)
Marginal health gains can be achieved by delivering other 
recommended treatments, at varying costs and net monetary 
benefits 
Adequate delivery of core (1st-line) treatments will reduce 
demand for less cost-effective treatments, reaping potential 
cost savings for the public healthcare system. 




Health Gain: Net Monetary Benefit:
3. Deliver all of the most cost-effective 
recommended treatments through 
coordinated programmes
Recommendations:
3: Remove funding silo barriers that impede delivery of the most recommended treatments 
within the public healthcare system.
1: Deliver the recommended core treatment(s) equitably, nationwide, through
coordinated OA management programmes.
4: Establish programmes for de-implementation of wasteful care delivery.
Stakeholders (people with OA, healthcare providers, Māori 
health advocates, healthcare delivery decision-makers and 
policy-makers, and OA experts) value the recommended 
treatments. 
For further information contact: haxby.abbott@otago.ac.nz
$25m/year 9000 QALYs/year $450m per year
$150m/year 11000 QALYs/year $400m per year
$140m/year 20000+ QALYs/year $1000m per year
What is known?
Internationally, clinical practice guidelines agree 
on the optimal core (1st-line) treatment for OA:
• Exercise therapy and physical activity
• Weight loss (where appropriate)




Second-line therapies, such as mood and sleep 
management, topical medications and heat therapy, 
and walking aids and assistive devices, can be useful 
adjuncts to core treatment.
3
Joint replacement surgery is effective and 
cost-effective for end-stage OA
Recommended core treatments are not routinely 
reaching New Zealanders with OA.
Many treatments that are not recommended are 
routinely funded and being delivered excessively.
(Opioids, long-term use of anti-inflammatory 
medications, repeat injections of corticosteroids)
Osteoarthritis (OA) is a leading cause of health losses and costs 
in NZ. The burden of OA is rising as a result of population ageing, 









5-year follow-up of a NZ randomized trial of 
exercise therapy showed long-term health gains 
and cost savings compared to usual care, due to 
reduced demand for other healthcare
1✓
Without changes to current practice, the 
burden of osteoarthritis will continue to rise
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